Accueil > Actualité
Actualite financiere : Actualite bourse

Novartis: gains positive opinion for new cholesterol drug

( - Novartis has received a positive opinion for Leqvio, its new treatment of high cholesterol, from the European Medicines Agency's Committee for Medicinal Products for Human Use, paving the way for potential approval of the drug.

Leqvio has a new mechanism of action which delivers sustained low-density lipoprotein cholesterol (LDL-C) reduction for patients with atherosclerotic cardiovascular disease and heterozygous familial hypercholesterolemia, a major driver of heart attacks and strokes.

The European Commission generally follows the recommendations made by the CHMP.

Copyright (c) 2020 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.